Larvol Delta - Signature-Cord-Prime-Receives-Investigational-New-Drug-IND-Approval-from-FDA-for-Phase-1-Study-in-Patients-with-Symptomatic-Osteoarthritis-of-the-Knee

Signature Cord Prime - Signature Biologics

https://www.prnewswire.com/news-releases/signature-cord-prime-receives-investigational-new-drug-ind-approval-from-fda-for-phase-1-study-in-patients-with-symptomatic-osteoarthritis-of-the-knee-301228588.html

Feb 16, 2021

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev